Evidence map›Paper›PMID 42857732›Full record

ArticleBlood immunology & cellular therapy2026

Glucocorticoid-induced TNF receptor ligand-dependent B-cell expansion of regulatory T cells as an immune cell therapy strategy.

Cody J Gurski, Mohamed Khalil, Kelli C Sommers, Angela K Beltrame, Bonnie N Dittel

Abstract read
In one paragraph

Article in Blood immunology & cellular therapy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Cody J GurskiVersiti Blood Research Institute, Milwaukee, WI.ORCID 0000-0001-7592-6367
Mohamed KhalilVersiti Blood Research Institute, Milwaukee, WI.ORCID 0000-0002-8331-1490
Kelli C SommersVersiti Blood Research Institute, Milwaukee, WI.ORCID 0000-0002-3906-4891
Angela K BeltrameVersiti Blood Research Institute, Milwaukee, WI.ORCID 0000-0003-0233-2618
Bonnie N DittelVersiti Blood Research Institute, Milwaukee, WI.ORCID 0000-0003-4275-2457

Funding

Development of a B Cell TherapeuticR01AI160244 · NIAID · VERSITI WISCONSIN, INC. · PI DITTEL, BONNIE N · 2020 to 2024
$3.4M
B cell-mediated immune regulationR56AI129348 · NIAID · VERSITI WISCONSIN, INC. · PI DITTEL, BONNIE N · 2017 to 2017
$451k
Mechanisms of a novel regulatory B cell subsetR56AI122655 · NIAID · VERSITI WISCONSIN, INC. · PI DITTEL, BONNIE N · 2016 to 2016
$418k
Mechanisms of Regulatory B Cell FunctionR56AI106672 · NIAID · VERSITI WISCONSIN, INC. · PI DITTEL, BONNIE N · 2013 to 2013
$392k
NIAID NIH HHS R01 AI160244NIAID NIH HHS R56 AI106672NIAID NIH HHS R56 AI122655NIAID NIH HHS R56 AI129348
6 · The paper itself

Abstract

B-cell-based immune cell therapies represent a potential strategy for restoring immune tolerance by expanding regulatory T cells (Tregs). CD4

Identifiers

PMID42857732
PMCPMC13651946

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.